A Study of a Single Dose of ALXN1210 in Healthy Participants
Clinical trial NCT05288660 · COMPLETED
Trial details
- NCT number
- NCT05288660
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-27
- Primary completion
- 2015-03-13
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.